Information Links
Mims
Main Navigation
Drugs
Conditions
News and resourcesNew drugs
Licensed melatonin treatment now available for children with autism
GPs can now prescribe melatonin as a licensed prolonged-release...
Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes
Prescribers can now consider Glyxambi (linagliptin/empagliflozin)...
New combination diabetes treatment launched
Suliqua is a titratable, fixed-ratio combination of...
Two new steroid inhalers launched
A new beclometasone metered-dose inhaler and a new...
NICE approves new diabetes treatment for NHS prescribing
Ertugliflozin (Steglatro), the newest sodium glucose...
New contraceptive vaginal ring launched
SyreniRing (ethinylestradiol/etonogestrel) is a contraceptive...
First topical treatment for premature ejaculation now available on prescription
Fortacin is the first topical treatment approved for...
New non-hormonal menopause treatment
Prescribers treating postmenopausal women with vulvar...
New injection allows weekly or monthly treatment of opioid dependence
Buvidal (buprenorphine) is licensed for the treatment...
Launch of new SGLT2 inhibitor increases choice in diabetes prescribing
Ertugliflozin (Steglatro) is a sodium glucose co-transporter...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
